Contraindications and Precautions: AOD-9604 should be avoided or used only under close medical supervision in individuals with active malignancy or history of cancer, as the effects of the peptide on tumor growth have not been adequately studied
The increased neutralizing capacity against the D614G-spike-bearing pseudovirus at 28 days from the booster compared to titers at a similar time point from the second dose suggests that the booster dose stimulated memory B-cells, thus resulting in a strong immune memory response
We do not warrant that the information provided is error-free
Maintain proper timing
Cats with these conditions or diseases are prone to being low on Vitamin B12 or (in the case of heart disease) needing extra
Administration record: Date of service, drug name, concentration, volume, route of administration, injection site, administering clinicians name and credentials, and patient response/tolerance